Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 383.00
-2.80 (-0.73%)
Feb 6, 2026, 4:59 PM CET
Novozymes Market Cap
Novozymes has a market cap or net worth of 179.65 billion as of February 6, 2026. Its market cap has decreased by -5.51% in one year.
Market Cap
179.65B
Enterprise Value
200.75B
Revenue
30.94B
Ranking
n/a
PE Ratio
27.02
Stock Price
383.00
Market Cap Chart
Since February 26, 2001, Novozymes's market cap has increased from 14.15B to 179.65B, an increase of 1,169.74%. That is a compound annual growth rate of 10.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 179.65B | -5.39% |
| Dec 30, 2025 | 189.89B | 0.24% |
| Dec 30, 2024 | 189.43B | 84.24% |
| Dec 29, 2023 | 102.82B | 5.66% |
| Dec 30, 2022 | 97.30B | -34.61% |
| Dec 30, 2021 | 148.80B | 51.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DSV A/S | 437.79B |
| Danske Bank | 268.97B |
| A.P. Møller - Mærsk | 223.57B |
| Ørsted | 184.09B |
| Vestas Wind Systems | 174.71B |
| Carlsberg | 129.20B |
| Genmab | 122.43B |
| Coloplast | 121.11B |